• Can changes in EEG improve neuropathic pain treatments - read Oct newsletter.
  • Nine posters ready to reveal at the SfN virtual conference 8-11 Nov, booth 1818.
  • Joined-up preclinical and clinical trials to advance psilocybin drug development
  • Transpharmation joins HaPpY team to help break the vicious cycle of chronic pain & mood disorders, see News for details
  • Announcing new premises in Poland with a focus on neuropsychiatric disorders...
  • New state-of-the-art premises at Discovery Park, Kent


News you can use


All the latest conference updates; those that we are attending and the studies that we are presenting

Advancing preclinical neuropathic pain research


A focus on sleep, depression and chemobrain in collaboration with the University of Hertfordshire.

For patients suffering with chronic neuropathic pain, (e.g. diabetes, chemotherapy) the need for suitable novel therapies is imperative. The key to developing new treatments lies in identifying measurable endpoints in both preclinical and human subjects to aid translation of preclinical results to the clinic.

Building on the impressive work that Transpharmation’s Dr Amy Fisher has already accomplished, we have partnered with Dr Lisa Lione's team at the University of Hertfordshire to successfully recruit multi award winning PhD student Michael Lanigan to focus exclusively on refining novel endpoints for our neuropathic pain assays. Michael was recently awarded the prestigious 2019 British Pharmacological Society Undergraduate Prize.

Using our strengths in EEG, MMN, cognition and biomarker analysis we will be working with UoH to better understand the behavioural and biochemical impact of pain and analgesia. We hope this work will create better translational preclinical research models, refine the drug discovery process for our clients and lead to the development of new medicines for patients suffering with neuropathic pain. If you would like to see our recent research in this area, please use this link to view the posters here View Posters


Start a Conversation

preclinical +44 (0)203 633 2807

clinical trials +353 (0)1896 42 60

clinical research +48 515 244 120

EEG contact@transpharmation.co.uk

Copyright ©2021 Transpharmation Ltd. Website created by Identity Ipswich Web Design